Houston vocabulary, from Texas law to the exam room. Sees no patients.
A prescription discussion and a payment decision are separate conversations. Ask the insurer about the exact product, form and reason for treatment being considered. Keep the answer with the plan name and the date of the discussion. If an answer is unclear, ask which document sets out the next step.
The terms here help read that document. They do not establish eligibility for any person. Use the insurer’s own explanation to distinguish a drug that can be considered for payment from one the plan has agreed to pay for in the specific case.
F
Formulary
The drug list used by a specific insurance plan.
The Medicare record checked September 26, 2026 made clear that a potentially coverable use still depended on the plan’s drug list and authorization process.(a)
Ask whether the exact planned product appears on the plan’s list and what conditions apply. Keep the ingredient and brand names together when asking. If the reply refers to a different form, return to the planned product. Ask for the wording in writing so it can be discussed with the prescriber without relying on memory.
M
Medicare Part D
Medicare’s prescription drug benefit, with rules tied to the medicine’s use.
As of September 26, 2026, the ordinary Part D benefit still excluded drugs when used for weight loss.(b)
Treatment for another medically accepted use could be considered for payment, with the plan’s terms still applying.(a)
Ask which use the payment discussion concerns rather than assuming the ingredient answers it. Keep a denial or request for more details with the care plan. Ask the insurer to identify what remains missing and who needs to provide it.
Medicare GLP-1 Bridge
A temporary payment demonstration that sits outside ordinary Part D payment.
The Bridge began July 1, 2026. Under Centers for Medicare & Medicaid Services (CMS) terms checked September 26, 2026, eligible people had a monthly copay of $50. The stated end date was December 31, 2027.(c)
The Bridge payment did not count toward Part D out-of-pocket totals, and it had no low-income subsidy.(c)
Eligibility had age, health, plan and prior-coverage conditions, including a separate route for people with type 2 diabetes.(d)
Ask the plan and prescriber which path applies before comparing the quoted amount with an ordinary plan copay.
P
Prior authorization
The plan asks for approval before agreeing to pay under its rules.
CMS required a prescription and prior authorization for the Bridge in its September 26, 2026 terms.(d)
Ask whose task it is to send the request. Ask what details the plan needs and where its reply will arrive. Keep proof of the response with any estimate. If more material is requested, ask who is responsible for sending it. Do not let an unresolved payment question disappear beneath an appointment confirmation. The goal is a clear account of the next action, not a guess about the outcome.
Keep the payment answer together
Does the reply refer to the exact medicine, form and use being considered?
What remains subject to review, and who will submit the requested material?
Which amount would be your responsibility under the written answer?
What payment route is being discussed: the plan benefit, a separate program or cash?